(Press-News.org) The animal tranquilizer xylazine is increasingly found in the illicit opioid supply nationwide, leading to severe wounds among people who use drugs. New research led by a University of Pittsburgh physician-scientist and published in Drug and Alcohol Dependence seeks to understand wound care experiences of this population.
A cross-sectional survey of people who use drugs identified through three syringe service providers in Massachusetts found the vast majority had experienced xylazine wounds in the prior year. As the need for comprehensive, low barrier wound care grows, access to such care continues to lag behind the demand. As a result, these wounds often lead to serious complications, such as infections, or become chronic, non-healing wounds necessitating amputation.
Of 171 individuals surveyed, 87% reported xylazine wounds. Among people who inject drugs, those with xylazine wounds were 10 times more likely to engage in subcutaneous injection. Nearly three-quarters (74%) reported experiencing health care stigma when seeking wound care and more than half (58%) reported inadequate pain and withdrawal management.
“Patients with xylazine wounds often don’t have access to low barrier wound care services that would address their substance use,” said lead author Raagini Jawa, M.D., M.P.H., UPMC addiction medicine and infectious diseases physician and assistant professor of medicine at Pitt. “When health systems do not respond to the rapidly changing drug supply, patients with xylazine wounds are forced to treat themselves.”
Proper wound healing requires specialized and consistent wound care, something not easily accessible to people who use drugs. Jawa’s previous research found that most addiction care providers nationwide are inadequately trained to provide proper wound care treatment and depend on referrals to external specialists.
More than half of survey respondents reported cleaning wounds with alcohol-based sanitizers which can be corrosive for a delicate wound bed and impact wound healing. Nearly 1 in 5 individuals did not cover their wounds because of a lack of access to appropriate wound care supplies. More than half of people surveyed also used heroin or fentanyl for pain caused by their xylazine wounds.
While the survey was conducted in Massachusetts, which has both syringe service and community-based drug-checking programs, the problem of xylazine wounds is even more pronounced in Pennsylvania. The Commonwealth leads the nation in xylazine entrenchment according to one measure.
“While we don’t yet fully understand the mechanism by which xylazine and other factors cause these wounds, we do know that there is an urgent need for high-quality, longitudinal wound care and linkage to addiction treatment, all provided without judgment,” said Jawa. “People with xylazine wounds need resources, education on how to care for their own wounds and compassionate care at every point that they touch the health care system – from the hospital to the emergency room to their PCP’s office.”
Jawa, with study co-author Margaret Shang, M.D., and colleague Ilana Hull, M.D. are leading efforts along with a multidisciplinary team of providers to streamline such care across UPMC, including distributing wound self-care resources and xylazine test strips to people who use drugs and developing systemwide protocols for other clinicians to follow.
Other authors on the study include Jane M. Liebschutz, M.D., M.P.H., Cristina Murray-Kerzen, Ph.D., M.S., Yihao Zheng, M.S. and Gary McMutrie, all of Pitt; Samia Ismail, M.P.H., and Michael Stein, M.D., both of Boston University; Stephen Murray, M.P.H., and Alexander Walley, M.D., M.Sc., both of Boston Medical Center; Sarah Mackin, M.P.H., and Kenny Washington, both of the Boston Public Health Commission; Pedro Alvarez, of Tapestry; and Jaime Dillon, of Life Connection Center.
This work was supported by the National Institute of Drug Abuse (NIDA) grant K12DA050607 and the 2023 Boston University School of Public Health Impact Grant.
END
Wounds are common among people who use illicit opioids, but proper wound care is hard to find
2024-08-22
ELSE PRESS RELEASES FROM THIS DATE:
Even as COVID raged, spikes in homicide were a significant drag on life expectancy for Black men
2024-08-22
MADISON — While the COVID-19 pandemic quickly reversed decades of progress in closing the gap between life expectancies for Black and white people in the United States, the disease’s toll may have obscured the impact of another significant public health concern — a sharp increase in homicide rates — on the life expectancy of Black men, according to researchers at the University of Wisconsin–Madison.
In 2019, Black men in the U.S. were expected to live an average of 71.4 years, ...
MD Anderson receives over $21.4 million in CPRIT funding to support research and launch new core facilities
2024-08-22
HOUSTON ― The University of Texas MD Anderson Cancer Center today was awarded nine grants totaling over $21.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of two new core facilities, faculty recruitment and groundbreaking cancer research across all areas of the institution.
“We are enormously appreciative of CPRIT’s support of impactful cancer research initiatives at MD Anderson,” said Peter WT Pisters, M.D., president of MD Anderson. “These new core facilities will help advance important areas of research in spatial biology and decision ...
Lehigh University is a core institution of new $26 Million NSF Engineering Research Center
2024-08-21
The U.S. National Science Foundation (NSF) has awarded $26 million to establish a new Gen-4 Engineering Research Center (ERC) named Environmentally Applied Refrigerant Technology Hub (EARTH) to create a sustainable and circular refrigerant economy.
The University of Kansas is the lead institution, joined by partners at Lehigh University, University of Notre Dame, University of Maryland, University of Hawai'i and University of South Dakota. David Vicic, the Howard S. Bunn Distinguished Professor of Chemistry, will lead Lehigh’s team. Mark Shiflett, University of Kansas Foundation Distinguished Professor in the Department of Chemical & Petroleum Engineering, will be the ERC EARTH ...
NJIT biologist awarded $680,000 federal grant to save North Atlantic right whale
2024-08-21
Brooke Flammang, a biologist at New Jersey Institute of Technology (NJIT), has been awarded nearly $680,000 from the National Oceanic and Atmospheric Administration (NOAA) as part of a growing nationwide effort to save the critically endangered North Atlantic right whale (Eubalaena glacialis).
NOAA Fisheries recently unveiled a more than $9 million initiative funded by the Inflation Reduction Act to support a coalition of universities, nonprofits and scientific organizations engaged in the recovery of the species, which has seen its numbers dwindle to roughly 360 individuals ...
University of Kansas awarded $26 million for new Engineering Research Center from National Science Foundation
2024-08-21
LAWRENCE — The National Science Foundation (NSF) has awarded the University of Kansas $26 million to establish a new Gen-4 Engineering Research Center (ERC) —Environmentally Applied Refrigerant Technology Hub (EARTH) — that will create a sustainable and circular refrigerant economy.
NSF’s Engineering Research Centers bring universities and businesses together to strengthen the competitive position of American industry in the global marketplace.
“NSF's Engineering Research Centers ask big questions in order to catalyze ...
Sandia Science & Technology Park injecting billions into state economy
2024-08-21
ALBUQUERQUE, N.M. — The Sandia Science & Technology Park is being credited with playing a critical role in New Mexico’s economy over the last 25 years, creating high-paying jobs and bringing state-of-the-art technologies to the marketplace.
A study by the Mid-Region Council of Governments shows that over that time, businesses located within the technology park paid out $7.7 billion in wages in the five-county region of Bernalillo, Sandoval, Valencia, Torrance and southern Santa Fe counties. It also shows the park generated ...
Marshall University innovators selected for prestigious NIH-funded entrepreneurship program
2024-08-21
HUNTINGTON, W.Va. – Two Marshall University innovators, Brad Profitt, DC, DPT, DScPT, and M’Hamed Turki, M.D., have been selected to participate in the National Institutes of Health (NIH) funded IDeA Regional Entrepreneurship Development (I-RED) Program, facilitated by the XLerator Network.
The NIH’s competitive I-RED program supports the creation of educational products to promote entrepreneurship in academic institutions. XLerator Health, a health care accelerator based in Louisville, Kentucky, assists startup founders like Profitt and Turki in commercializing their businesses and attracting funding.
Profitt is a co-founder ...
Lipid nanoparticle mRNA therapy improves survival in mouse models of maple syrup urine disease
2024-08-21
New Rochelle, NY, August 21, 2024—Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here to read the article now.
The researchers, led by James Wilson, M.D., Ph.D., from the University of Pennsylvania, Perelman School of Medicine, evaluated a lipid nanoparticle-based treatment approach to address all possible genetic mutations that can cause MSUD.
“Repeated intravenous ...
USAMMDA commercial partner receives FDA emergency use authorization for plasma powder
2024-08-21
A U.S. Army Medical Materiel Development Activity commercial partner received Emergency Use Authorization from the U.S. Food and Drug Administration for the Department of Defense to use octaplasLG Powder—a potentially lifesaving treatment option for blood replacement therapies in certain operational circumstances. Notice of the EUA for this product was received by the company, Octapharma USA, on Aug. 8, 2024.
USAMMDA’s Warfighter Protection and Acute Care Project Management Office, which has a Cooperative Research and Development Agreement with Octapharma USA, manages research and development efforts for several ...
Pennington Biomedical study to explore effects of soy on blood sugar levels
2024-08-21
Pennington Biomedical Research Center’s Dr. Candida Rebello wants to know more about the intersection of blood sugar levels and a diet rich in soy. This intersection is the primary focus of her new study, “Lifestyle Intervention for Improving Metabolic and Motivational Outcomes,” or MOTIVATE, which explores how specific diets can impact blood sugar, and potentially improve mood and energy levels.
When soy seeds are cut, they produce the anti-microbial compound known as glyceollin, which has been shown to improve insulin sensitivity and cognition. The cut soy seeds will be milled into flour and will be included in the diets of some of the participants. The MOTIVATE ...